DOCSLIB.ORG

A Constructivist Vision of the First-Trimester Abortion Experience

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Constructivist Vision of the First-Trimester Abortion Experience HHr Health and Human Rights Journal A Constructivist Vision of the First-TrimesterHHR_final_logo_alone.indd 1 10/19/15 10:53 AM Abortion Experience sam rowlands and jeffrey wale Abstract How might the abortion experience look in a world without the existing regulatory constraints? This paper critically assesses the evidence about how a high-quality abortion experience might be achieved in the first trimester. There would need to be positive obligations on states in pursuance of women’s reproductive rights. The onus would be on states and state actors to justify interferences and constraints upon a woman’s right to terminate in the first trimester of her pregnancy. In this vision, abortion is person-centered and normalized as far as possible. High-quality information about abortion would be freely available through multiple sources and in varying formats. Whenever possible, abortion would happen in a place chosen by the woman, and in the case of medical abortion, could be self-managed with excellent clinical backup on hand should the need arise. The overarching purpose of this paper is to highlight the broader environment and framework of state obligations necessary to underpin the lived experience of abortion. Sam Rowlands, LLM, MD, FRCGP, FFSRH is Visiting Professor in the Department of Medical Sciences and Public Health at Bournemouth University, Bournemouth, UK. Jeffrey Wale, LLB, PhD, PGCE, FHEA, is Senior Lecturer in Law in the Department of Humanities and Law at Bournemouth University, Bournemouth, UK. Please address correspondence to Sam Rowlands. Email: [email protected]. Competing interests: None declared. Copyright © 2020 Rowlands and Wale. This is an open access article distributed under the terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited. JUNE 2020 VOLUME 22 NUMBER 1 Health and Human Rights Journal 237 s. rowlands and j. wale / general papers, 237-249 Introduction outside the womb may soon be possible (ectogen- esis), we assume that some demand for abortion Criminalization of abortion has well-known (as currently envisaged) will persist.3 Necessarily, 1 deleterious effects. Much has been written on these assumptions limit the transferability of this decriminalization of abortion, specifying what framework in the real world, but our intention is 2 legislation needs to be dismantled. In contrast, to encourage policy makers and reformers to think we adopt a ‘constructivist’ approach, looking at critically about the possibilities that a constructiv- what is needed to support a high-quality abortion ist approach might offer should the opportunity experience, drawing upon research and literature arise for genuine reform. Further, our purpose is that includes the lived experience of women who to highlight that in the absence of direct regulato- have undergone abortion. We set aside regulatory ry constraints, it is the broader environment and constraints that could hinder progress toward framework of state obligations that underpin the giving people with a uterus (in the interest of brev- lived experience of abortion. ity, ‘women’ is used hereafter) the ability to freely Defining quality in abortion care is at an early choose how they respond to an unwanted pregnan- stage, despite abortion being such a commonplace cy. As far as possible, we have used a fresh sheet occurrence. There is no standardized, validated of paper. We take a ground-up approach, building set of quality metrics for abortion as there are, from scratch and beginning with no abortion-spe- for example, for maternity services.4 This paper cific laws at all. does not focus on safety, effectiveness, timeliness, Although we use the term ‘abortion’ through- efficiency, and equitability; there is a considerable out this paper, we recognize that this may be 5 construed as a loaded term with preconceived body of work on these. Instead, we concentrate connotations. In keeping with our constructivist on person-centeredness as a major ingredient of approach, we use the term simply to denote the a high-quality abortion experience. Person/pa- steps necessary to bring about the end of an estab- tient-centered care means an approach that informs lished pregnancy (that is, after implantation of the and engages women (and partners, if appropriate) in embryo). These steps would, in the ordinary course their own individual health care and also to engage 6 of events, result in ending the life of the unborn service users in health care service co-design. We entity or entities. assume that appropriate regulatory mechanisms re- main in place to maintain the safety of all abortion services.7 Starting points and core assumptions We do not assume that women will have di- In this paper, we make several core assumptions. rect contact with health services. This is in line First, we assume that the state has unlimited with current World Health Organization think- resources to address its positive and negative ob- ing, the general principles of self-care, and the ligations to pregnant women. Second, we assume experiences and perceptions of women who have that those resources are distributed fairly, justly, undertaken self-management of medical abor- and equally within society. Third, we make no at- tion.8 We do, however, acknowledge that there tempt to accommodate the plurality in this vision. are still some research gaps on self-managed There is no sense that competing views require abortion; for example, how best to inform and accommodation or that compromises are necessary support women in using the medicines safely and in the regulatory rules. Fourth, our vision does not effectively and how to facilitate the community seek to erase the private sphere, or any socio-po- distribution of high-quality drugs and information.9 litical objections to, or prejudices against abortion. We know that many women have opted, for Rather, our focus is on a world without pre-existing various reasons, for “informal sector” abortions, regulatory constraint on the choices that women even when they are entitled to a legal abortion in can make in this context. Fifth, although gestation the formal (approved) health sector.10 On the face of 238 JUNE 2020 VOLUME 22 NUMBER 1 Health and Human Rights Journal s. rowlands and j. wale / general papers, 237-249 it, this may seem like a second-best option, but as abortion undertaken outside the formal health some women positively opt for self-managed abor- system. Although ambulatory (outpatient) medical tion at home, it is no longer an act of desperation: abortion is generally limited to 10 weeks’ gestation, “self-managed abortion can be a source of reprieve the envelope continues to be pushed on this upper or escape from … indignities of formal settings limit. The World Health Organization recommends and experiences of shame and powerlessness with- self-managed medical abortion up to 12 weeks’ in them.”11 We regard self-managed first-trimester gestation, conceding that evidence is limited for the medical abortion (that is without attending a health upper two weeks.15 Further, we are on slightly eas- facility)—following evidence-based regimens ier ethical ground in the first trimester, whether on using drugs from approved sources, with full in- a rights, personhood, or relational perspective. Our formation—as safe. Self-management could be starting point is that state actors have a much hard- supplemented by advice from an approved authori- er time justifying constraints on pregnant women ty such as a pharmacist or an appropriately trained during the first trimester, partly because there is community activist. more common ground about the moral status of the Unless appropriately registered, licensed, and unborn entity at this stage of development. Conse- trained, procedures undertaken by informal abortion quently, any margin of appreciation that might be providers such as herbalists, street vendors, and tra- granted to states and their agents ought to be nar- ditional birth attendants are potentially unsafe. For rowly construed during this stage of pregnancy.16 the avoidance of any doubt, we are not seeking to Some of the thinking behind this paper has directly constrain the choices of pregnant women. been stimulated by innovative organizations that Rather, our concern is to ensure that women are not provide internet-based abortion services and there- harmed or subjected to the unnecessary risk of sig- by empower women.17 Although women choose to nificant harm by the supply of inaccurate/ inadequate use these services, the organizations only provide information or the provision of deficient abortion medical abortion and so by definition offer no services. Accordingly, we suggest that informal ser- choice within their service provision. Although vice providers, rather than pregnant women, should the development of drugs for medical abortion has be the target of any future regulatory constraints. been a revolutionary scientific advance, in many Our aim is to minimize recourse to untrained ser- high-resource countries medical abortion now vice providers by delivering improved access to the tends to dominate service provision to the exclu- formal (approved) and publicly funded sector. In our sion of surgery.18 Surgery obviously requires direct vision, the formal sector and those who work in it are contact with health professionals. But first-trimes- subject to regulation in relation to the standard and ter surgical abortion can be provided safely outside quality of pre-/post-abortion care. a hospital setting with simple equipment, and sat- When women are asked what they want in isfaction with manual vacuum aspiration is high.19 abortion services, they identify minimal delay as However, unless aspiration is available on demand, a priority.12 Women who have decided to termi- it is not a genuine option; for example, a weekly nate a pregnancy want their abortion procedure operating list is not sufficient.
Load more

Recommended publications
  • Parental Consent Form for a Minor Seeking Abortion
    Parental Consent Form for a Minor Seeking Abortion Parental Statement: I certify that I, ___________________________, am the parent of _________________________________ (name of parent) (minor daughter name) and give consent for ____________________________ to perform an abortion on my daughter. I understand (physician name) that any person who knowingly makes a fraudulent statement in this regard commits a felony. Date: , 20 . Signature of Parent/Managing Conservator/Guardian I certify I have witnessed the execution of this consent by the parent. Subscribed and sworn to before me on this day of 20 (day) (month) Seal NOTARY PUBLIC in and for The State of OKLAHOMA My commission expires: Required attachments: - Copy of government-issued proof of identification - Written documentation that establishes that he or she is the lawful parent of the pregnant female Physician Statement: I, ____________________________, certify that according to my best information and belief, a reasonable person under (Physician name) similar circumstances would rely on the information presented by both the minor and her parent as sufficient evidence of identity. Date: , 20 . Signature of Physician ___________ (Parent Initials) Oklahoma State Department of Health 11/2013 Health Care Information Page 1 of 9 Consent of a Minor & Parental Consent Statement The law of the State of Oklahoma (Title 63, Section 1-740.13) requires physicians to obtain the consent of the minor and parent using this form prior to performing an abortion on a minor who is not emancipated.
    [Show full text]
  • Steps for Performing Manual Vacuum Aspiration (MVA) Using the Ipas MVA Plus® and Ipas Easygrip® Cannulae
    Steps for Performing Manual Vacuum Aspiration (MVA) Using the Ipas MVA Plus® and Ipas EasyGrip® Cannulae Step One: Prepare the Patient Step Six: Prepare the Aspirator • Administer pain medication before the • Position the plunger all the way inside procedure to have maximum effect when the the cylinder. procedure begins. • Have collar stop in place with tabs in the • Give prophylactic antibiotics to all women, or cylinder holes. therapeutic antibiotics if indicated. • Push valve buttons down and forward • Ask the woman to empty her bladder. until they lock (1). • Conduct a bimanual exam to confirm uterine • Pull plunger back until arms snap size and position. outward and catch on cylinder base (2). • Insert speculum and observe for signs of infection, bleeding or incomplete abortion. Step Seven: Suction Uterine Contents • Attach the prepared aspirator to the cannula. Step Two: Perform Cervical • Release the vacuum by Antiseptic Prep pressing both buttons. • Use antiseptic-soaked sponge to clean • Evacuate the contents of the cervical os. Start at os and spiral outward uterus by gently and slowly without retracing areas. Repeat until os has rotating the cannula 180° been completely covered by antiseptic. in each direction, using an in-and-out motion. • When the procedure is finished, depress the buttons and disconnect the cannula from the aspirator. Alternatively, withdraw the cannula and Step Three: Perform Paracervical Block aspirator without depressing the buttons. • Paracervical block is required prior to MVA. • Perform paracervical block with Signs that indicate the uterus is empty: 20cc of 1% lidocaine, or 10cc • Red or pink foam without tissue is seen passing through the cannula.
    [Show full text]
  • First Trimester Abortion Guidelines and Protocols Surgical and Medical Procedures from Choice, a World of Possibilities
    From choice, a world of possibilities First trimester abortion guidelines and protocols Surgical and medical procedures From choice, a world of possibilities IPPF is a global service provider and a leading advocate of sexual and reproductive health and rights for all. We are a worldwide movement of national organizations working with and for communities and individuals. IPPF works towards a world where women, men and young people everywhere have control over their own bodies, and therefore their destinies. A world where they are free to choose parenthood or not; free to decide how many children they will have and when; free to pursue healthy sexual lives without fear of unwanted pregnancies and sexually transmitted infections, including HIV. A world where gender or sexuality are no longer a source of inequality or stigma. We will not retreat from doing everything we can to safeguard these important choices and rights for current and future generations. Acknowledgments Written by Marcel Vekemans, Senior Medical Advisor, International Planned Parenthood Federation (IPPF) Central Office. The IPPF Abortion Team gratefully acknowledges the contributions of the reviewers of the guidelines and protocols: Kiran Asif, Cherie Etherington-Smith, Jennifer Friedman, Pak-Cheung Ho, Rebecca Koladycz, Celal Samad, Nono Simelela and Tran Nguyen Toan. Printing this publication was made possible through the financial contribution of an anonymous donor. Upeka de Silva’s contributions were essential to bring this publication to fruition. Inside these guidelines
    [Show full text]
  • Ipas US Start-Up Kit for Integrating Manual
    Ipas U.S. Start-up Kit for Integrating Manual Vacuum Aspiration (MVA) for Early Pregnancy Loss into Women’s Reproductive Health-care Services MVASUK2-E09 Ipas U.S. Start-up Kit for Integrating Manual Vacuum Aspiration (MVA) for Early Pregnancy Loss into Women’s Reproductive Health-care Services Acknowledgements This document was developed by Ipas’s Programs Unit. Primary contributors include Ruth Arick, Donna Ruscavage, Deborah VanDerhei and Justine Wu (medical protocols). Special thanks to Laura Castleman, Rodolfo Gomez and Bill Powell for their work on the medical protocols; and the other Ipas staff persons who contributed to this document. Special thanks to Emily Ann Batchelder for copyediting and Jamie McLendon for graphic design. Ipas works globally to increase women’s ability to exercise their sexual and reproductive rights and to reduce abortion-related deaths and injuries. We seek to expand the availability, quality and sustainability of abortion and related reproductive-health services, as well as to improve the enabling environment. Ipas believes that no woman should have to risk her life or health because she lacks safe reproductive-health choices. ISBN: 1-933095-48-2 © 2009 Ipas. This publication may be reproduced in whole or in part without permission, provided the material is distributed free of charge and the publisher and authors are acknowledged. Produced in the United States of America. Suggested citation: Ipas. 2009. Ipas Start-up Kit for integrating manual vacuum aspiration (MVA) for early pregnancy loss into women’s reproductive health-care services. Chapel Hill, NC: Ipas. This document is the second edition of the Ipas Start-up Kit for integrating manual vacuum aspiration (MVA) and medication technologies into women’s reproductive health-care services.
    [Show full text]
  • Menstrual Regulation: a Potential Breakthrough in Fertility Control
    MENSTRUAL REGULATION: A POTENTIAL BREAKTHROUGH IN FERTILITY CONTROL G. DAVIS and D. M. POTTS Population Services International, 103-105 Harley Street, London, W.1, and International Planned Parenthood Federation, 18-20 Lower Regent Street, London SW1Y 4PW INTRODUCTION Menstrual regulation (menstrual aspiration, endometrial aspiration, menses extraction, menses induction) is vacuum curettage of the uterus performed either at, or within a few days of, the expected date of menstruation in women in whom it is possible that unplanned, unwanted conception has occurred. The technique is not new. Simpson (1872) who attended Queen Victoria in childbirth, described what he called 'dry cupping' of the uterus. Solish (1970) points out that some of the more striking results described by Simpson are probably attributable to having terminated very early pregnancies. In 1927, Bykov described the use of a small syringe and cannula as a method of fertility regulation. In practice, the procedure used was one of menstrual regulation, although the author's own tortuous physiological explanation depended upon a theory of encouraging endometrial hyperaemia to prevent implantation. In the 1950s, Wu & Wu (1958), in the People's Republic of China, described the use of a hand-syringe to terminate very early pregnancies. An analogous technique has been used as a diagnostic procedure for some years, especially in Scandinavia. In this latter case, experience of several thousand cases shows the procedure to be simple, safe and virtually without complications, even though it was used mostly on women with pre-existing pelvic pathology. Diagnostic aspiration of this type has been found safe as an outpatient/office procedure (E.
    [Show full text]
  • Dilatation and Curettage Versus Manual Vacuum Aspiration for First Trimester Clandestine Abortions
    International Journal of Reproduction, Contraception, Obstetrics and Gynecology Nkwabong E et al. Int J Reprod Contracept Obstet Gynecol. 2015 Jun;4(3):716-720 www.ijrcog.org pISSN 2320-1770 | eISSN 2320-1789 DOI: 10.18203/2320-1770.ijrcog20150079 Research Article Dilatation and curettage versus manual vacuum aspiration for first trimester clandestine abortions Elie Nkwabong*, Joseph Nelson Fomulu Department ofof Obstetrics & Gynecology, Faculty of Medicine and Biomedical Sciences/University Teaching Hospital, Yaoundé, Cameroon Received: 20 March 2015 Revised: 31 March 2015 Accepted: 09 May 2015 *Correspondence: Dr. Elie Nkwabong, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Background: Unintended pregnancy rate is rising worldwide and most of these pregnancies end by clandestine abortion. This study aimed at comparing complications of clandestine abortions done with Manual Vacuum Aspiration (MVA) to those of clandestine abortions done with Dilatation and Curettage (D&C). Methods: This retrospective descriptive study was carried out in the Yaoundé University Teaching Hospital (Cameroon) from March 1st to August 31st, 2012. Abortions carried out with MVA or D&C were recruited. Main variables studied were abortionist, method used, complications presented and hospital stay. Data were analyzed using SPSS 18.0. Analyses included the t test and the Fisher exact test. The level of significance was P <0.05. Results: Main abortionists were nurses and general practitioners.
    [Show full text]
  • Medication Abortion a Guide for Health Professionals
    MEDICATION ABORTION A GUIDE FOR HEALTH PROFESSIONALS ABOUT IBIS REPRODUCTIVE HEALTH Ibis Reproductive Health aims to improve women’s reproductive health, choices, and autonomy worldwide. Our work includes clinical and social science research, policy analysis, and evidence-based advocacy. Ibis Reproductive Health has offices in Cambridge, MA and San Francisco, CA (USA) and Johannesburg, South Africa. Information about Ibis Reproductive Health, including a list of publications and a summary of our current projects, can be found at www.ibisreproductivehealth.org. Copies of this reader can be obtained by contacting admin@ ibisreproductivehealth.org. Ibis Reproductive Health 2 Brattle Square Cambridge, MA 02138 Phone: 001-617-349-0040 Fax: 001-617-349-0041 Cover design by Christine DeMars: www.demarsdesign.com Cover image: Detail of a Koran frontispiece based on a decagon grid. Egypt, 14th century. W ilson E. Islamic designs for artists & craftspeople. London: British Museum Publications, 1988. MEDICATION ABORTION A GUIDE FOR HEALTH PROFESSIONALS Author Angel M. Foster, DPhil, AM Translated by Aida Rouhana, MPH & Hafsa Zubaidi, MA Acknowledgements W e would like to thank the following individuals for providing feedback and reviewing earlier drafts of this manuscript: Ms. Katrina Abuabara, Dr. Charlotte Ellertson, Dr. W illiam Fawzy, Dr. Daniel Grossman, Mr. Emad Mancy, Ms. Kate Schaffer, Dr. Beverly W inikoff, Dr. Lisa W ynn W e are grateful to the W illiam and Flora Hewlett Foundation whose funding made this bi-lingual guidebook a reality. This guidebook is dedicated to the memory of Dr. Charlotte Ellertson Visionary, mentor, colleague and friend ii TABLE OF CONTENTS Introduction… … … … … … … … … … … … … … … … … … … … … … … … … … … … 1 The medications of abortion… … … … … … … … … … … … … … … … … … ..… … … .
    [Show full text]
  • 5. Uterine Aspiration Procedure Manual Vacuum Aspiration (Mva) Electric Vacuum Aspiration (Eva)
    5. UTERINE ASPIRATION PROCEDURE MANUAL VACUUM ASPIRATION (MVA) ELECTRIC VACUUM ASPIRATION (EVA) This section contains information on early uterine aspiration with manual and electric vacuum, used for both abortion* and management of early pregnancy loss. You will train in the use of vacuum equipment, steps in the uterine aspiration procedure, and tissue evaluation. Although most early uterine aspiration procedures are technically straightforward, some present challenges. Management of the more complex cases and complications will also be discussed. CHAPTER LEARNING OBJECTIVES Following chapter completion and hands-on experience, you should be better able to: □ List the steps of the uterine aspiration procedure and tips for dilation. □ Identify and correctly use equipment for manual vacuum aspiration. □ Consistently use the ‘no touch technique’ while providing uterine aspiration, and describe its importance. □ Evaluate products of conception for presence of appropriate gestational tissue. □ Assess and manage challenges and complications related to uterine aspiration. READINGS / RESOURCES: □ National Abortion Federation (NAF). Management of Unintended and Abnormal Pregnancy (Paul M. et al, Wiley-Blackwell, 2009) • Chapter 10: First Trimester Aspiration Abortion • Chapter 13: The Challenging Abortion • Chapter 15: Surgical Complications: Prevention and Management * “Aspiration abortion” is the term we use instead of “surgical abortion”, as suggested in Weitz et al. 2004. First-trimester abortions are most often completed through either electric or manual aspiration – typically simple procedures that can be safely undertaken in a regular exam room, with local &/or oral analgesics and little recovery time. The abortion procedure can also be called “suction abortion.” Use of the term “surgical” connotes cutting of tissue, in a process likely to take place in a hospital operating room.
    [Show full text]
  • Manual Vacuum Aspiration: a Safe and Effective Treatment for Early Miscarriage
    Manual vacuum aspiration: A safe and effective treatment for early miscarriage Surgical management of early pregnancy loss has advantages over medical treatment. For one, patients benefit from a brief procedure using local anesthesia. Here, pearls for office-based surgery as well as other treatment options. Piyapa Praditpan, MD, MPH, and Anne R. Davis, MD, MPH CASE Miscarriage in a 29-year-old woman intervention. The management options A woman (G0P0) presents to her gynecologist include surgical, medical, and expectant. with amenorrhea for 3 months and a positive Women should be offered all 3 of these, and home urine pregnancy test. She is 29 years clinicians should explain the risks and bene- of age. She denies any bleeding or pain and fits of each approach. But while each strategy IN THIS intends to continue the pregnancy, though it ARTICLE can be safe, effective, and acceptable, many was unplanned. Results of office ultrasonogra- women, as well as their health care provid- Advantages of phy to assess fetal viability reveal an intrauter- ers, will benefit from office-based uterine office-based MVA ine gestation with an 8-mm fetal pole but no aspiration. In this article, we present the data page 39 heartbeat. The diagnosis is miscarriage. available on office-based manual vacuum as- piration (MVA) as well as procedure pointers his case illustrates a typical miscar- and urge you to consider MVA in your prac- Medical riage diagnosis; most women with tice for your patients. management T miscarriage are asymptomatic and page 40 without serious bleeding requiring emergency Surgical management Current diagnostic Surgical management of miscarriage offers criteria Dr.
    [Show full text]
  • Manual Vacuum Aspiration for Treatment of Early Pregnancy Loss Guideline
    Manual Vacuum Aspiration for Treatment of Early Pregnancy Loss Guideline Contributors: Adam B. Tyson, MD; Benjie B. Mills, MD; John Van Deman, MD Updated: 10/20/18 Background Manual vacuum aspiration (MVA) is a safe, effective therapy for failed intrauterine pregnancy in the first trimester. It can be performed in a variety of clinical settings such as the office, obstetric unit, or emergency department, and offers the advantages of rapidity and reduced cost. The efficacy of MVA is similar to electric vacuum aspiration at 98-99%. General anesthesia can be avoided as only oral analgesia and local anesthesia with a paracervical block are needed. Indications and Contraindications for MVA • Indications ❧ Treatment of incomplete or missed abortion when the estimated size of the gestational sac or products is 10 weeks or less. ❧ Evacuation of the uterus in a pregnancy of unknown location (PUL) after determination that no chance of a normal or viable intrauterine pregnancy exists • Absolute Contraindications ❧ Patient requests sedation or general anesthesia ❧ Known or suspected molar pregnancy ❧ Septic abortion ❧ Medically unstable patient ❧ Medically complicated or uncontrolled medical disorders causing concern for patient safety ❧ Known ectopic pregnancy without the possibility for failed heterotopic pregnancy • Relative Contraindications ❧ Patients with increased risk of bleeding such as anticoagulation, platelet abnormalities, factor deficiencies, or other bleeding disorders ❧ Abnormalities of the uterus or cervix which could increase the risk of failure of the procedure or increase the risk of complication, such as significant cervical stenosis, congenital anomalies of the uterus, or known intrauterine pathology unrelated to the failed pregnancy Counseling • Document all counseling in the medical record.
    [Show full text]
  • Preventing Unsafe Abortion and Its Consequences Priorities for Research and Action
    Priorities for Action Research and Abortion Preventing and Unsafe its Consequences nsafe abortion is a significant yet preventable cause of maternal mortality and morbidity. The Ugravity and global incidence of unsafe abortion Preventing call for a better understanding of the factors behind the persistence of unsafe abortion and of the barriers to preventing unsafe abortion and managing its conse- Unsafe Abortion quences. This volume brings together the proceedings from an inter-disciplinary consultation to assess the and its global and regional status of unsafe abortion and to identify a research and action agenda to reduce unsafe abortion and its burden on women, their families, and Consequences public health systems. The volume addresses a compre- hensive range of issues related to research on prevent- ing unsafe abortion, outlines regional priorities, and Priorities for identifies critical topics for future research and action on preventing unsafe abortion. Research and Action Iqbal H. Iqbal Shah H. Warriner Ina K. Editors Ina K. Warriner Iqbal H. Shah cover 4.indd 1 31/01/2006 13:34:26 Preventing Unsafe Abortion and its Consequences Priorities for Research and Action Editors Ina K. Warriner Iqbal H. Shah A-Intro.indd 1 09/02/2006 10:44:45 Suggested citation: Warriner IK and Shah IH, eds., Preventing Unsafe Abortion and its Consequences: Priorities for Research and Action, New York: Guttmacher Institute, 2006. 1. Abortion, Induced - adverse effects 2. Abortion, Induced - epidemiology 3. Women’s health services 4. Health priorities
    [Show full text]
  • Dilatation & Evacuation (D&E) Reference Guide
    Dilatation & Evacuation (D&E) Reference Guide INDUCED ABORTION AND POSTABORTION CARE AT OR AFTER 13 WEEKS GESTATION (‘SECOND TRIMESTER’) © 2017, 2018 Ipas ISBN: 1-933095-98-9 Citation: Edelman, A. & Kapp, N. (2018). Dilatation & Evacuation (D&E) Reference Guide: Induced abortion and postabortion care at or after 13 weeks gestation (‘second trimester’). Chapel Hill, NC: Ipas. Ipas works globally so that women and girls have improved sexual and reproductive health and rights through enhanced access to and use of safe abortion and contraceptive care. We believe in a world where every woman and girl has the right and ability to determine her own sexuality and reproductive health. Ipas is a registered 501(c)(3) nonprofit organization. All contributions to Ipas are tax deductible to the full extent allowed by law. For more information or to donate to Ipas: Ipas P.O. Box 9990 Chapel Hill, NC 27515 USA 1-919-967-7052 www.ipas.org Cover photo: © Richard Lord The photographs used in this publication are for illustrative purposes only; they do not imply any particular attitudes, behaviors, or actions on the part of any person who appears in the photographs. Printed on recycled paper. Dilatation & Evacuation (D&E) Reference Guide: INDUCED ABORTION AND POSTABORTION CARE AT OR AFTER 13 WEEKS GESTATION (‘SECOND TRIMESTER’) Alison Edelman Senior Clinical Consultant, Ipas Professor, OB/GYN Oregon Health & Science University Nathalie Kapp Associate Medical Director, Ipas MD, MPH About Ipas Ipas works globally so that women and girls have improved sexual and reproductive health and rights through enhanced access to and use of safe abortion and contraceptive care.
    [Show full text]